Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Transfusion. 2013 Apr 29;54(1):179–189. doi: 10.1111/trf.12217

Figure 4. Recipient inflammation with poly (I:C) enhances anti-KEL responses, with “boostable” responses.

Figure 4

(A) Serum anti-KEL glycoprotein IgG responses in C57BL/6 animals transfused with KEL2 RBCs in the presence or absence of recipient poly (I:C) pretreatment; straight serum, 14 days post-transfusion. (B) Serum anti-KEL glycoprotein IgG responses after 1, 2, or 3 KEL2 RBC transfusions in the presence of poly (I:C); sera diluted 1:10, tested every 14 days. Results are representative of 2–3 experiments with 3–5 mice/group; *p<0.05